This inventor holds 38 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 30 EPO patents, primarily in Cancer Therapeutics. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Merck + Co., Inc.. Active years: 2009-2026.
Location History:
- Boston, MA (US) (2009 - 2019)
- Brookline, MA (US) (2014 - 2022)
- Newton, MA (US) (2021 - 2024)
Company Filing History:
33 out of 2,405 
4 out of 63 
1 out of 4,770 
Years Active: 2009-2026
Areas of Expertise:
Title: The Innovative Contributions of David L. Sloman
Introduction: David L. Sloman, based in Brookline, MA, is a prolific inventor with 30 patents to his name. His work has significantly impacted the pharmaceutical industry, particularly in the development of novel therapeutic agents.
Latest Patents: Among his most recent patents are two groundbreaking inventions. The first, titled "Arginase Inhibitors and Methods of Use," details compounds of Formula I, which serve as arginase inhibitors that can aid in preventing and treating arginase-related diseases. His second patent, "PRMT5 Inhibitors," introduces a compound of Formula I, alongside its pharmaceutically acceptable salts, esters, and prodrugs. This invention offers methods for treating conditions such as cancer and specific genetic mutations, demonstrating the broad therapeutic potential of his work.
Career Highlights: David has made considerable strides in his career, having worked with prominent companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His contributions in these roles reflect a deep commitment to advancing healthcare through innovation.
Collaborations: Throughout his career, Sloman has collaborated with notable colleagues, including David James Witter and Matthew G. Stanton. These collaborations highlight a network of skilled professionals working towards common goals in the field of pharmaceuticals.
Conclusion: David L. Sloman's impressive portfolio of patents and collaborations demonstrates his significant contributions to modern medicine. His innovative spirit continues to inspire progress in the treatment of complex diseases, underscoring his role as a leading inventor in the pharmaceutical realm.